Description
Disease-focused foundations raise and distribute billions of dollars of research funding which has historically been directed to research grants at academic centers and in supporting clinical trials. Over the last decade, the re-shaping of the drug R&D landscape is shifting the roles and influences of disease-focused foundations as they are becoming increasingly active in bridging the translational chasm of early drug discovery and development. In this session, thought leaders from disease-focused foundations will discuss the rise of these organizations in the R&D process as well as the factors contributing to shifting roles, current engagement, sustainability and growth, risks and risk-mitigation strategies and future trending.

Session ID: 22251

Tags